# Spike #1 Feasibility Report + Go/No-Go Recommendation

Date (UTC): 2026-02-22  
Phase: POC  
Owner: Tech Lead / PM (draft prepared by integrator)

## Scope recap

Target critical path:
`fragments -> cluster -> layout -> render -> explore -> save/load`

Implemented in this spike:
- Deterministic atlas generation with `theme` and `intensity` cluster modes
- Interactive Pixi map with pan/zoom/select
- Save/load snapshot API and UI controls with UI context restoration
- QA matrix execution with 10/10 scenarios recorded as PASS
- Evidence artifacts captured in `docs/02-poc/evidence/`

## Evidence references

- Acceptance checklist: `docs/02-poc/03-SPIKE-1-ACCEPTANCE.md`
- QA results: `docs/02-poc/12-QA-TEST-MATRIX.md`
- Perf budgets + latest snapshot: `docs/02-poc/09-PERFORMANCE-BUDGETS.md`
- Perf evidence note: `docs/02-poc/evidence/perf-snapshot-2026-02-22.md`
- Defect state: `docs/02-poc/13-DEFECT-LOG.md`
- UI capture: `docs/02-poc/evidence/poc-ui-stage-qa.png`

## Bottlenecks and limitations

1. API timing precision is low (`Date.now()`), causing coarse `generationMs` values on fast runs.
2. Stress evidence is currently synthetic/manual; no automated FPS telemetry yet.
3. Demo artifact is screenshot-based; no motion capture (GIF/video) yet for richer gate review.

## Risk posture

- Product risk: Moderate (meaningfulness still heuristic-based, but explainable)
- Technical risk: Low-to-moderate (core flows stable; telemetry precision and richer perf observability pending)
- Delivery risk: Low for immediate POC continuation

## Recommendation

Decision: **GO (conditional)** for continued POC progression and MVP-prep planning.

Conditions to close before formal POC gate sign-off:
1. Add high-resolution perf instrumentation in API timing.
2. Record PM + Tech Lead + QA explicit sign-off note against this report.

## Proposed next execution slice

1. Implement precise timing instrumentation (`performance.now`/perf hooks) in API response metrics.
2. Run sign-off review and complete `docs/02-poc/15-SPIKE-1-SIGNOFF-RECORD.md`.
